Specifically, CDX1 has been reported to play vital roles in gastric intestinal metaplasia, and the identified miR-296-5p-CDX1-ERK1/2 axis elucidates our the understanding of the progression from intestinal metaplasia to gastric cancer [44]. This evidence concerns the gene MAPK3 and gastric cancer.